Cellestial Health is a spin-out from the University of Cambridge, but did you know that we have academic collaborations across the UK and globally – including with the University of Manchester. Our connection with Manchester started in the summer 2024 at the Innovation Lab event which welcomed four industry partners to team up with the excellent local academic leaders and apply for pilot grant translational funding, together.
Dr Nat Hastings, CEO of Cellestial Health, remarked:
“I found the <expertise> matching event by Translation Manchester quite unique and very helpful. For most funding applications, if a crucial piece of expertise is missing, the funding opportunity may be lost for a whole year or longer, and a promising idea may never get a chance to take off even if we know that the correct support is available somewhere within our network. Translation Manchester helps to both make connections within the ecosystem and support these newly formed collaborations with rapidly available translational capital, giving new partnerships a real momentum to grow into long-term, fruitful relationships.”
The match-making was successful, and a new project searching for astrocytic pathology biomarkers in the human cerebrospinal fluid commenced. Our new team did not stop there as novel ideas grew in the past six months – so watch this space for upcoming updates.
Find out more about the Innovation Lab 2024 program and see photos from the day: